C-reactive protein and neutrophil count laboratory test requests from primary care: what is the demand and would substitution by point-of-care technology be viable?

Abstract

Aims C-reactive protein (CRP) and neutrophil count (NC) are important diagnostic indicators of inflammation. Point-of-care (POC) technologies for these markers are available but rarely used in community settings in the UK. To inform the potential for POC tests, it is necessary to understand the demand for testing. We aimed to describe the frequency of CRP and NC test requests from primary care to central laboratory services, describe variability between practices and assess the relationship between the tests.MethodsWe described the number of patients with either or both laboratory tests, and the volume of testing per individual and per practice, in a retrospective cohort of all adults in general practices in Oxfordshire, 2014–2016.Results372 017 CRP and 776 581 NC tests in 160 883 and 275 093 patients, respectively, were requested from 69 practices. CRP was tested mainly in combination with NC, while the latter was more often tested alone. The median (IQR) of CRP and NC tests/person tested was 1 (1–2) and 2 (1–3), respectively. The median (IQR) tests/practice/week was 36 (22–52) and 72 (50–108), and per 1000 persons registered/practice/week was 4 (3–5) and 8 (7–9), respectively. The median (IQR) CRP and NC concentrations were 2.7 (0.9–7.9) mg/dL and 4.1 (3.1–5.5)×109/L, respectively.ConclusionsThe high demand for CRP and NC testing in the community, and the range of results falling within the reportable range for current POC technologies highlight the opportunity for laboratory testing to be supplemented by POC testing in general practice.

Diagnostic accuracy of blood tests of inflammation in paediatric appendicitis: a systematic review and meta-analysis

“…17 18 All these blood tests can be available within hours and are also increasingly available rapidly as point-of-care (POC) tests thus extending their future application to expediate the clinical decision-making process and broaden their use into community care. 19 Clinical scoring tools, which can incorporate clinical signs and blood results, can be used to triage patients at hospital to determine the need for imaging or surgery. 20 Although the clinical prediction scores are recommended their reported accuracy and uptake varies widely, and use is more limited in children.…”

“…Much of the evidence for their accuracy in this setting is applied from adult studies 17 18. All these blood tests can be available within hours and are also increasingly available rapidly as point-of-care (POC) tests thus extending their future application to expediate the clinical decision-making process and broaden their use into community care 19…”

Home-built environment interventions and inflammation biomarkers: a systematic review and meta-analysis protocol

“… 32 GPs commonly request blood test combinations that check for abnormal inflammation in patients such as C-reactive protein (CRP), full blood count, glycated haemoglobin, ferritin and/or neutrophil count. 33 , 34 Their usefulness as surrogate endpoints has been confirmed in clinical trials in multiple cancer types. 35 …”